-
281
-
282
-
283
-
284
Characteristics of CanPath participants (N = 134,404) who completed the follow-up questionnaire.
Foilsithe / Cruthaithe 2025Ábhair: -
285
Descriptives of substance use for all CanPath participants who completed the follow-up questionnaire.
Foilsithe / Cruthaithe 2025Ábhair: -
286
Odds ratios of e-cigarette use (95% CIs) by neighborhood characteristics.
Foilsithe / Cruthaithe 2025Ábhair: -
287
Odds ratios of cannabis use (95% CIs) by neighborhood characteristics.
Foilsithe / Cruthaithe 2025Ábhair: -
288
Odds ratios of cigarette use (95% CI) by neighborhood characteristics.
Foilsithe / Cruthaithe 2025Ábhair: -
289
Interplay between Carbonate Phases in the NaNO<sub>3</sub>‑Promoted Carbonation of MgO
Foilsithe / Cruthaithe 2025Ábhair: -
290
-
291
-
292
-
293
-
294
Kidney bacterial burden in mice infected with MRSA wild-type, Δ<i>yqhG</i>, and complemented strains.
Foilsithe / Cruthaithe 2025Ábhair: -
295
-
296
Crystal violet quantification of biofilm formation in MRSA wild-type, ΔyqhG, and complemented strains.
Foilsithe / Cruthaithe 2025Ábhair: -
297
-
298
Survival data of BALB/c mice infected with MRSA wild-type, Δ<i>yqhG</i>, and complemented strains.
Foilsithe / Cruthaithe 2025Ábhair: -
299
-
300
Morris water maze performance across acquisition and reversal phases.
Foilsithe / Cruthaithe 2025Ábhair: